MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK.
MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; Paediatric Endocrinology, Southampton University Hospitals NHS Foundation Trust, Southampton SO16 6YD, UK.
Bone. 2017 Nov;104:29-38. doi: 10.1016/j.bone.2017.01.024. Epub 2017 Jan 22.
Osteoporosis constitutes a major public health problem, through its association with age-related fractures, particularly of the hip, vertebrae, distal forearm and humerus. Substantial geographic variation has been noted in the incidence of osteoporotic fractures worldwide, with Western populations (North America, Europe and Oceania), reporting increases in hip fracture throughout the second half of the 20th century, with a stabilisation or decline in the last two decades. In developing populations however, particularly in Asia, the rates of osteoporotic fracture appears to be increasing. The massive global burden consequent to osteoporosis means that fracture risk assessment should be a high priority among health measures considered by policy makers. The WHO operational definition of osteoporosis, based on a measurement of bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA), has been used globally since the mid-1990s. However, although this definition identifies those at greatest individual risk of fracture, in the population overall a greater total number of fractures occur in individuals with BMD values above the threshold for osteoporosis diagnosis. A number of web-based tools to enable the inclusion of clinical risk factors, with or without BMD, in fracture prediction algorithms have been developed to improve the identification of individuals at high fracture risk, the most commonly used globally being FRAX®. Access to DXA, osteoporosis risk assessment, case finding and treatment varies worldwide, but despite such advances studies indicate that a minority of men and women at high fracture risk receive treatment. Importantly, research is ongoing to demonstrate the clinical efficacy and cost-effectiveness of osteoporosis case finding and risk assessment strategies worldwide. The huge burden caused by osteoporosis related fractures to individuals, healthcare systems and societies should provide a clear impetus for the progression of such approaches.
骨质疏松症是一个主要的公共卫生问题,它与年龄相关的骨折有关,特别是髋部、脊柱、远端前臂和肱骨骨折。全球范围内,骨质疏松性骨折的发病率存在显著的地域差异,西方人群(北美、欧洲和大洋洲)报告称,20 世纪后半叶髋部骨折的发病率一直在增加,而在过去二十年中,这一发病率已经稳定或下降。然而,在发展中国家人群中,特别是在亚洲,骨质疏松性骨折的发生率似乎正在增加。骨质疏松症所带来的巨大全球负担意味着,骨折风险评估应该成为政策制定者考虑的健康措施中的重中之重。自 20 世纪 90 年代中期以来,世界卫生组织(WHO)基于双能 X 射线吸收法(DXA)测量骨密度(BMD)的骨质疏松症操作性定义已在全球范围内使用。然而,尽管这一定义确定了那些骨折风险最大的个体,但在总体人群中,BMD 值高于骨质疏松症诊断阈值的个体发生骨折的总数更多。已经开发了许多基于网络的工具,以便在骨折预测算法中纳入临床危险因素,无论是否结合 BMD,从而提高对高骨折风险个体的识别能力,全球最常用的工具是 FRAX®。DXA 的使用、骨质疏松症风险评估、病例发现和治疗在全球范围内存在差异,但尽管取得了这些进展,研究表明,只有少数高骨折风险的男性和女性接受了治疗。重要的是,正在进行研究以证明全球范围内骨质疏松症病例发现和风险评估策略的临床疗效和成本效益。骨质疏松症相关骨折给个人、医疗保健系统和社会带来的巨大负担应该为这些方法的推进提供明确的动力。